A 15 year old girl with a family history of type 1 multiple endocrine adenomatosis presented with reversible neurological disturbances, hypoglycaemia and hyperinsulinaemia. Initial radiology was normal, but portal venous sampling suggested an insulinoma in the tail ofthe pancreas which was removed with conservation of the spleen. Hypoglycaemia persisted despite high doses ofdiazoxide and intravenous dextrose. A second laparotomy revealed a pancreatic endocrine tumour and sub-total pancreatectomy was performed. Histology revealed islet cell microadenomatosis. Hypoglycaemia persisted despite treatment with somatostatin analogues and 40% intravenous dextrose was required to maintain normoglycaemia. A possible lesion near the splenic hilum on computed tomographic scan was reported as a splenunculus although further peripheral, hepatic and portal venous sampling suggested hepatic or systemic lesions. A positron emission scan and selective visceral angiography suggested a lesion in the left upper quadrant. Acute lactic acidosis, rhabdomyolysis and renal failure supervened. Post mortem revealed the putative 'splenunculus' to be a residual insulinoma, whilst the splenic vein was thrombosed, accounting in part for discrepant venous sampling data.
Introduction
Hyperinsulinism associated with type 1 multiple endocrine adenomatosis (MEA) is often the consequence of multiple benign insulinomas or diffuse microadenomatosis.' ' Consequently, management strategy may be rather different than for solitary insulinomas.
Case history A 15 year old girl, previously well, presented in August 1986 with episodes of reversible neurological disturbances. During one episode ofconvulsions, hypoglycaemia of 1.5 mmol/l was noted.
Subsequently frequent hypoglycaemia and inappropriate hyperinsulinaemia (245 pmol/l, normal under 30pmol/1), elevated C-peptide levels (1.56 pmol/l, normal under 1.5 pmol/l), and mild hyperchloraemic acidosis associated with elevated parathyroid hormone levels (94 pg/ml, normal under 50 pg/ml) were recorded. There was a family history of type 1 MEA. Her father had previously had surgery for pituitary and parathyroid adenomata and gastroduodenal surgery for recurrent peptic ulceration, due to presumed gastrinoma. Two brothers had presented with peptic ulceration at the age of 16 years.
An insulinoma was suspected, but abdominal computed tomographic (CT) scan Simultaneous peripheral and hepatic venous sampling showed high levels of insulin and proinsulin in branches of the hepatic vein, but peripheral levels appeared higher than central levels, after correction for differences in albumin concentration. A bronchial carcinoid secreting insulin was considered, but a thoracic CT scan showed no abnormality. The abdominal CT scan was repeated at this examination and was again reported as normal, with the exception of a putative splenunculus, which was also demonstrated on review of the previous CT scans (Figure la, Significant post-operative hypoglycaemia recurred, which required intravenous dextrose, diazoxide and intermittent parenteral glucagon. Glucagon produced rises in blood glucose but this was associated with subsequent rebound peripheral hyperinsulinaemia and hypoglycaemia.
In March 1988, hepatic arteriography demonstrated a small lesion in the splenic hilum corresponding to the putative splenunculus. The splenic vein was thrombosed and it was commented that the drainage from this area could consequently be via collaterals into the azygos vein. Central venous sampling again showed highest insulin levels in the portal vein, and a hepatic tumour with anomalous drainage was considered. Hypoglycaemia at this time was severe enough to necessitate 8 hourly infusions of 20% dextrose in addition to 1 g diazoxide. Somatostatin infused at a rate of 250-500 SAg/h effectively suppressed insulin levels and produced a slightly delayed peripheral hyperglycaemic response (Figure 2) .
Positron emission tomography (PET) suggested a left upper quadrant lesion and selective visceral angiography, with injection of the remnant of the dorso-pancreatico-duodenal artery, demonstrated a tumour blush in the midline, anterior to the T12/L1 disc interspace.
Unfortunately the patient's condition deteriorated. She refused to continue with oral diazoxide which had caused severe hirsutism and fluid retention, and became fatigued, nauseated, pyrexial, anaemic and hypokalaemic. A further abdominal CT scan (the sixth) was reported as showing extensive fatty change in the liver and the 'presumed splenunculus was again noted at the splenic hilum'. Severe hypoglycaemia persisted and 40% intravenous glucose via a central line was required to maintain normoglycaemia. Cultures of blood and of the central line were negative and further abdominal and pelvic CT scans unhelpful. She developed severe lactic acidosis, rhabdomyolysis and renal failure and died on the 15 July 1988.
Post mortem examination revealed generalized oedema, severe mediastinal and peritoneal haemorrhage, necrotizing myopathy, and a tumour at the splenic hilum attached to normal pancreatic tail tissue. This was subsequently confirmed on histology to be an insulinoma. No splenunculus was seen and there was no evidence of pituitary, parathyroid, thyroid or adrenal adenomata.
Discussion
This case raises the issue of the optimum approach to diagnosis and management of hyperinsulinaemia associated with type 1 MEA in a young patient. Many reports on the diagnosis and treatment of insulinoma57 refer to sporadic cases with solitary tumours, which may on occasion metastasize, whereas it is evident from studies in type 1 MEA that hyperinsulinism is due to benign multi- In addition, other features of this case merit discussion:
Imaging of lesions It was ironic that the residual insulinoma which was implicated in the patient's eventual demise had been visualized on at least 4 abdominal CT scans, and was also located by hepatic arteriography. However, the appearance was consistently reported as a splenunculus despite considerable discussion on this point, and this certainly had a bearing on further surgical management. Although the vascularity and the density of the enhanced CT image were not thought to be typical of aberrant pancreatic tissue, similar density of splenic and insulinoma tissue on CT scan following injection of contrast is recognized and was misleading in this case. However, it is reasonable to suggest in retrospect, whether or not a splenunculus had been present, that the nesidioblastosis/apudomas of type 1 MEA could be expected to develop in developmental anomalies such as a splenunculus. The use of endoscopic ultrasound in the current case proved misleading in the localization of the tumour. Such difficulties in localization of multiple endocrine adenomata have previously been recognized in at least one report.9
Blood samplingfor insulin Although it is said that transhepatic venous sampling may give the highest chance of accurate localization,1 peripheral and central insulin and proinsulin levels suggested, at various times, hepatic 'metastases', a bronchial carcinoid, or a continued source of insulin/proinsulin secretion in the distribution of the pancreatico-duodenal circulation. In our patient, the anomalous venous drainage from the tumour at the splenic hilum, secondary to thrombosis of the splenic vein or to previous surgery, contributed to these discrepancies. It fig/h ).
The response to the somatostatin analogue was rather disappointing, although it should be noted that low doses only were used owing to presumptive side effects and the hope at the time that curative surgical treatment was imminent. On reflection, there would have been a case for the reintroduction of higher doses of the somatostatin analogue, perhaps in conjunction with chemotherapy, but the patient's condition deteriorated when this option was being considered.
Longer term management of persistent hypoglycaemia The hypoglycaemia appeared more aggressive after each diagnostic and therapeutic intervention, and this necessitated administration of high concentrations ofintravenous glucose. This probably led to fatty infiltration of the liver and fluid retention, which together with the lack of absorption of dietary protein and fat, may have contributed to the metabolic acidosis and myopathy which led to renal failure and death.
It is possible that earlier aggressive hormonal treatment and chemotherapy might have led to lower glucose requirements which might have helped protect the liver from severe fatty infiltration.'01'2
In conclusion, insulinomas in type 1 MEA are frequently multiple, and careful, extensive preoperative localization of tumours is necessary. However, diagnostic techniques for the localization of insulinomas must be interpreted with great caution. Initial radical appropriate surgical treatment may be curative and hormonal treatment can be beneficial, while unopposed high concentrations of intravenous dextrose and nutritional imbalance may be particularly dangerous.
